MK-8669; AP23573; Ridaforolimus
572924-54-0
990.2
C53H84NO14P
DMF, DMSO, Ethanol
-20°C
Deforolimus is a small-molecule inhibitor of the mammalian target of rapamycin (mTOR). Blocking mTOR creates a starvation-like effect in cancer cells by interfering with cell growth, division, metabolism, and angiogenesis.
0.1 lbs
Substance Name:N-Debenzoyl-N-(t-butoxycarbonyl)-10-deacetyltaxol; Taxotere; RP-56976; NSC-628503
CAS Number:114977-28-5
Substance Name:3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one; 2',7-Dihydroxy-3,4-benzocoumarin
CAS Number:1143-70-0
Substance Name:N-Debenzoyl-N-(t-butoxycarbonyl)-10-deacetyltaxol; Taxotere; RP-56976; NSC-628503
CAS Number:114977-28-5
Substance Name:5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Substance Name:3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one; 2',7-Dihydroxy-3,4-benzocoumarin
CAS Number:1143-70-0
Substance Name:5-Amino-7-(cyclohexylamino)-1-ethyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid
Substance Name:3,8-Dihydroxy-6H-dibenzo[b,d]pyran-6-one; 2',7-Dihydroxy-3,4-benzocoumarin
CAS Number:1143-70-0